Less Restrictive Medicaid Policies for Direct‐Acting Antiviral Access Are Associated With Greater Declines in Hepatocellular Carcinoma Deaths

Documenti analoghi

• Heterogeneous effects of Medicaid expansion on food security measures
  di: Anne T. Byrne, et al.
  Pubblicazione: (2024)
• Prediction of Hepatocellular Carcinoma After Direct‐Acting Antiviral Therapy Using Agile 3+ and End‐of‐Treatment Alpha‐Fetoprotein Levels in Patients With Hepatitis C
  di: Akifumi Kuwano, et al.
  Pubblicazione: (2025)
• Editorial: Direct‐Acting Agents and Risk of Hepatocellular Carcinoma—The End of Controversy
  di: Vincent Haghnejad, et al.
  Pubblicazione: (2025)
• Correction to ‘Risk of Hepatocellular Cancer in U.S. Patients With Compensated Cirrhosis Treated With Direct‐Acting Antivirals Versus Interferon’
  Pubblicazione: (2025)
• Risk of Hepatocellular Carcinoma Decreases After Antiviral Therapy–Induced HBsAg Seroclearance
  di: Han Ah. Lee, et al.
  Pubblicazione: (2025)